Versant Capital Management »

Design Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $534 71 7.54

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Microsoft Stock (MSFT)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Ishares S&p Global Energy Etf (IXC)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)

View all positions for Versant Capital Management

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Point72 Asset Management
BlackRock
Frazier Life Sciences Management
Tang Capital Management
Baker Bros. Advisors
Almitas Capital
Vanguard Group
Driehaus Capital Management
Kynam Capital Management
FMR
Geode Capital Management
State Street Corporation
Acadian Asset Management

View all funds holding Design Therapeutics